SCHEMBL16509221

SCHEMBL16509221

Cc1ccc2nc(-c3ccc(NC(=O)Cc4ccc(Cl)cc4)cc3)n(O)c2c1

nearest known ligand 0.61

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ RORC P51449 18/20 0.61
▸ TP53 P04637 1/20 0.58
▸ MAPT P10636 1/20 0.58
▸ KDR P35968 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16509173 0.90 RORC (0.67) RORC
SCHEMBL16509180 0.89 RORC (0.65) RORC
SCHEMBL16509250 0.88 MAPT (0.51) RORCTP53MAPTKDR
SCHEMBL16509184 0.88 KDM4E (0.59) RORC
SCHEMBL14922047 0.85 ALDH1A1 (0.61) RORCMAPT
SCHEMBL16509270 0.84 RORC (0.54) RORC
SCHEMBL16509188 0.83 RORC (0.56) RORC
SCHEMBL16509198 0.83 RORC (0.65) RORC
SCHEMBL14922045 0.82 MEN1 (0.56) RORC
SCHEMBL16509260 0.81 RORC (0.48) RORCKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110306611-A1 Transcription factor modulating compounds and methods of use thereof PARATEK PHARMACEUTICALS, INC. (US) 2011-12-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110306611-A1 Transcription factor modulating compounds and methods of use thereof JUN, CREBBP, TFEB RORC 614/4885TP53 2559/4885MAPT 4415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback